Utilizing registries in systemic lupus erythematosus clinical research

References

• Gliklich RE, Dreyer NA. Registries For Evaluating Patient Outcomes: A User’s Guide (2nd Edition). AHRQ Publication No. 10-EHC049, Agency for Healthcare Research and Quality, Rockville, MD, USA (2010).
   Google Scholar
• De Rooy DPC, van der Linden MPM, Kneven R, Huizinga TWJ, van der Helm-van Mil AHM. Predicting arthritis outcomes – what can be learned from the Leiden early arthritis clinic? Rheumatology50, 93–100 (2011).
   PubMed Web of Science ®Google Scholar
• Mariette X, Gottenberg JE, Ravaud P, Combe B. Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology50, 222–229 (2011).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. The national data bank for rheumatic diseases: a multi registry rheumatic disease data bank. Rheumatology50, 16–24 (2011).
   PubMed Web of Science ®Google Scholar
• Kremer JM. The CORRONA database. Autoimmun. Rev.5, 46–54 (2006).
   PubMed Web of Science ®Google Scholar
• McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh K. Incidence of systemic lupus erythematosus. Arthritis Rheum.38, 1260–1270 (1995).
   PubMed Web of Science ®Google Scholar
• Lu LJ, Wallace DJ, Navarra SV, Weisman MH. Lupus registries: evolution and challenges. Semin. Arthritis Rheum.39, 224–245 (2010).
   PubMedGoogle Scholar
• Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies and the hierarchy of research designs. N. Engl. J. Med.342, 1887–1892 (2000).
   PubMed Web of Science ®Google Scholar
• Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N. Engl. J. Med.342, 1907–1909 (2000).
   PubMed Web of Science ®Google Scholar
• Feinstein AR. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann. Intern. Med.99, 843–848 (1983).
   PubMed Web of Science ®Google Scholar
• White E, Hunt JR, Casso D. Exposure measurement in cohort studies: the challenges of prospective data collection. Epidemiol. Rev.20, 43–56 (1998).
   PubMed Web of Science ®Google Scholar
• Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology. Little, Brown and Company, MA, USA, 228 (1985).
   Google Scholar
• Hennekens CH, Buring JE. Epidemiology in Medicine (1st Edition). Little, Brown and Company, MA, USA (1987).
   Google Scholar
• Rothman K, Greenland S. Modern Epidemiology (3rd Edition). Lippincott Williams & Wilkins, PA, USA (1998).
   Google Scholar
• Szklo M. Population-based cohort studies. Epidemiolo. Rev.20, 81–90 (1998).
   PubMed Web of Science ®Google Scholar
• Salim A, Hultman C, Sparén P, Reilly M. Combining data from 2 nested case–control studies of overlapping cohorts to improve efficiency. Biostatistics10, 70–79 (2009).
   PubMedGoogle Scholar
• Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes AW, Grobbee DE, Moons KGM. Advantages of the nested case–control design in diagnostic research. BMC Med. Res. Methodol.8, 48 (2008).
   PubMedGoogle Scholar
• Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K. For the MORGAM project. Case–cohort design in practice – experiences from the MORGAM project. Epidemiol. Perspect. Innovat.4, 15 (2007).
   PubMedGoogle Scholar
• Prentice RL. A case–cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika73, 1–11 (1986).
   Web of Science ®Google Scholar
• Petri M. Clinical research in systemic lupus erythematosus: immediate relevance to clinical practice. Int. J. Rheumat. Dis.14, 1–5 (2011).
   PubMedGoogle Scholar
• Bookman AAM, Urowitz MB, Koehler BE. The bimodal pattern of mortality in systemic lupus erythematosus (SLE). J. Rheumatol.1, 57 (1974) (Abstract).
   Google Scholar
• Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodalmortality pattern of systemic lupus erythematosus. Am. J. Med.60, 221–225 (1976).
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Ibañez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J. Rheumatol.34, 70–75 (2007).
   PubMed Web of Science ®Google Scholar
• Bajaj S, Albert L, Gladman DD et al. Serial renal biopsy in systemic lupus erythematosus. J. Rheumatol.27, 2822–2826 (2000).
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Gladman DD. Contributions of observational cohort studies in systemic lupus erythematosus: the University of Toronto lupus clinic experience. Rheumatol. Dis. Clin. N. Am.31, 211–221 (2005).
   PubMedGoogle Scholar
• Nikpour M, Urowitz MB, Ibañez D, Gladman D. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis Rheum.61, 1152–1158 (2009).
   PubMed Web of Science ®Google Scholar
• Petri M. Lupus in Baltimore: evidence-based ‘clinical pearls’ from the Hopkins lupus cohort. Lupus14, 970–973 (2005).
   PubMedGoogle Scholar
• Barr S, Zonana-Nacach A, Magder L, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum.42, 2682–2688 (1999).
   PubMed Web of Science ®Google Scholar
• Petri M, Perez-Gutthann S, Longenecker JC, Hochberg MC. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am. J. Med.91, 345–353 (1991).
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J, Goldman DW. The Hopkins lupus pregnancy center: 1987–1991 update. Am. J. Reprod. Immunol.28, 188–191 (1992).
   PubMed Web of Science ®Google Scholar
• Petri M, Lakatta C, Magder L, Goldman DW. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am. J. Med.96, 254–259 (1994).
   PubMed Web of Science ®Google Scholar
• Petri M, Rheinschmidt M, Whiting-O’Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of 60 consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody. Ann. Intern. Med.106, 524–531 (1987).
   PubMedGoogle Scholar
• Petri M. The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins lupus cohort. Thromb. Res.114, 593–595 (2004).
   PubMed Web of Science ®Google Scholar
• Siedner MJ, Gelber AC, Rovin BH et al. Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis. J. Rheumatol.35, 84–90 (2008).
   PubMedGoogle Scholar
• Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Med. (Baltimore)85, 147–156 (2006).
   PubMed Web of Science ®Google Scholar
• Uribe AG, McGwin G Jr, Reveille JD, Alarcón GS. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. Nurture) cohort? Where are we heading? Autoimmun. Rev.3, 321–329 (2004).
   PubMed Web of Science ®Google Scholar
• Fessler BJ, Alarcón GS, McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum.52, 1473–1480 (2005).
   PubMed Web of Science ®Google Scholar
• Fernández M, Calvo-Alén J, Bertoli AM et al. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA LII): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. J. Clin. Rheumatol.13, 261–265 (2007).
   PubMed Web of Science ®Google Scholar
• Fernández M, Alarcón GS, Calvo-Alén J et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum.57, 576–584 (2007).
   PubMed Web of Science ®Google Scholar
• Alarcón GS, McGwin G, Bertoli AM et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic U.S. cohort (LUMINA L). Ann. Rheumatol. Dis.66, 1168–1172 (2007).
   PubMed Web of Science ®Google Scholar
• Bertoli AM, Alarcon GS, Calvo-Alén J, Fernandez M, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum.54, 1580–1587 (2006).
   PubMed Web of Science ®Google Scholar
• Tucker L, Uribe A, Fernández M et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic U.S. cohort (LUMINA LVII). Lupus17, 314–322 (2008).
   PubMed Web of Science ®Google Scholar
• Andrade RM, Alarcón GS, Fernández M et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic U.S. cohort. Arthritis Rheum.56, 622–630 (2007).
   PubMed Web of Science ®Google Scholar
• Pons-Estel GJ, Gonzalez LA, Zhang J et al. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology48, 817–822 (2009).
   PubMed Web of Science ®Google Scholar
• Calvo-Alén J, McGwin G, Toloza S et al. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study. Ann. Rheumatol. Dis.65, 785–790 (2006).
   PubMed Web of Science ®Google Scholar
• Pons-Estel BA, Catoggio LJ, Cardiel MH et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore)83, 1–17 (2004).
   PubMed Web of Science ®Google Scholar
• Shinjo SK, Bonfá E, Wojdyla D et al. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheum.62, 855–862 (2010).
   PubMed Web of Science ®Google Scholar
• Alarcón GS, McGwin G Jr, Petri M et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus11, 95–101 (2002).
   PubMed Web of Science ®Google Scholar
• Alarcón GS, McGwinJr G, Petri M et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med.10, 1949–1956 (2006).
   Google Scholar
• Peschken CA, Katz SJ, Silverman E et al. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. J. Rheumatol.36, 1200–1208 (2009).
   PubMed Web of Science ®Google Scholar
• Lalani S, Pope J, de León F, Peschken C. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J. Rheumatol.37, 38–44 (2010).
   PubMed Web of Science ®Google Scholar
• Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Med. (Baltimore)82, 299–308 (2003).
   PubMed Web of Science ®Google Scholar
• Cervera R, Abarca-Costalago M, Abramovicz D et al. (European working party on systemic lupus erythematosus). Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the “Euro-Lupus Project”. Autoimmun. Rev.5, 180–186 (2006).
   PubMedGoogle Scholar
• Houssiau FA, Vasconcelos C, D’Cruz D et al. The 10-year follow-up data of the Euro-Lupus nephritis trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann. Rheumatol. Dis.69, 61–64 (2010).
   PubMed Web of Science ®Google Scholar
• Gladman D, Ginzler E, Goldsmith C et al. Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J. Rheumatol.19, 1820–1821 (1992).
   PubMed Web of Science ®Google Scholar
• Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum.39, 363–369 (1996).
   PubMed Web of Science ®Google Scholar
• Urowitz M, Gladman D, Ibañez D et al. Atherosclerotic vascular events in a multinational inception cohort of SLE. Arthritis Care Res. (Hoboken)62, 881–887 (2010).
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Gladman DD, Ibañez D et al. Evolution of disease burden over five years in a multicentre inception SLE cohort. Arthritis Care Res.64(1), 132–137 (2012).
   PubMed Web of Science ®Google Scholar
• Hanly JG, Urowitz MB, Sanchez-Guerrero J et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum.56, 265–273 (2007).
   PubMed Web of Science ®Google Scholar
• Hanly JG, Urowitz MB, Siannis F et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an internationalinception cohort study. Arthritis Rheum.58, 843–853 (2008).
   PubMed Web of Science ®Google Scholar
• Hanly JG, Urowitz MB, Su L et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of SLE patients. Ann. Rheumatol. Dis.69, 529–535 (2010).
   PubMed Web of Science ®Google Scholar
• Hanly JG, Urowitz MB, Jackson D et al. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in SLE. Ann. Rheumatol. Dis.70, 961–967 (2011).
   PubMedGoogle Scholar
• Yelin E, Trupin L, Katz P et al. Work dynamics among persons with SLE. Arthritis Care Res.57, 56–63 (2007).
   Web of Science ®Google Scholar
• Yazdany J, Tonner C, Trupin L et al. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res. Thera.12(3), R84 (2010).
   Web of Science ®Google Scholar
• Thibauly Flesher DL, Sun X, Behrens TW, Graham RR, Criswell LA. Recent advances in the genetics of SLE. Exp. Clin. Immunol.6, 461–479 (2010).
   Google Scholar
• Taylor KE, Chung SA, Graham RR et al. Risk alleles for SLE in a large case–control collection and associations with clinical subphenotypes. PLoS Genet.7(2), E1001311 (2011).
   PubMed Web of Science ®Google Scholar
• Adrianto I, Wen F, Templeton A et al. Association between a functional variant downstream of TNFAIP3 and systemic lupus erythematosus. Nat. Genet.43, 253–258 (2011).
   PubMed Web of Science ®Google Scholar
• Tan W, Sunahori K, Zhao J et al. Association of PPP2CA polymorphisms with SLE susceptibility in multiple ethnic groups. Arthritis Rheum.63, 2755–2763 (2011).
   PubMedGoogle Scholar
• Rasmussen A, Sevier S, Kelly JA et al. The lupus family registry and repository. Rheumatology50, 47–59 (2011).
   PubMedGoogle Scholar
• Bloom S. Registries in chronic disease: coming your way soon? Rheumatology50, 4–5 (2011).
   PubMedGoogle Scholar
• Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmune Rev. doi:10.1016/j.autrev.2011.10.020 (2011) (Epub ahead of print).
   Google Scholar